Skip to main content
Caplight Logo









Onego Bio

Onego Bio

Private
HelsinkiEnergy & Sustainabilityhttps://onego.bio

Last Round

Series A

Extension

Jul 17, 2024

Est. Valuation

$84.8M

Total Funding Raised

$70.8M

Company Overview

Onego Bio operates in Energy & Sustainability and is based in Helsinki. Its latest recorded funding round was a Series A Extension round in July 2024.

Onego Bio is a food-biotech company that produces animal-free egg protein through precision fermentation.

Sector

Energy & Sustainability

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Onego Bio Comparables

Compare Onego Bio with similar companies based on industry and business-model similarity.

Onego Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The EVERY Company
85%
Revyve
84%
PoLoPo
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Onego Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJul 17, 2024
Series AApr 2, 2024
GrantSep 7, 2022
SeedFeb 22, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Christopher Landowski

Co-Founder and CTO

Founding Team

Maija Itkonen

CEO & Co-founder

Founding Team

For institutional investors. Book with your work email.

Onego Bio Investors

Notable investors and investment history

Onego Bio investors
InvestorRounds
Agronomics LimitedSeries A, Seed
European Innovation Council FundSeries A Extension
TesiSeries A
European Commission (Horizon Europe)Series A Extension
Business FinlandGrant, Series A
HoldixSeries A
EIT FoodSeries A
Book a demo to see all 14 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 9, 2026

    Collaborating with Sigma Foods on egg-free protein solutions.

  • Feb 4, 2026

    Dr. Antti Vasara appointed to the board of directors.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • expands_facilitiesOct 13, 2026

    Onego Bio Ltd plans a production facility in Wisconsin.

  • files_suit_againstOct 12, 2026

    A Delaware court dismisses Onego Bio Ltd's lawsuit against EVERY Co. on Oct 9th '26, ending the case filed in Fall '25 over ovalbumin patent validity, alleged infringement, licensing fees, and tortious interference.

  • has_issues_withOct 11, 2026

    Onego Bio Ltd faces a dispute over whether it infringes The EVERY Company's "foundational" patent covering ovalbumin expression in a range of hosts, while a Delaware court dismisses the lawsuit on Oct 9th '26 without deciding patent validity or infringement.

Book a demo to see all news

For institutional investors. Book with your work email.

Onego Bio Filings

Explore SEC and related filing metadata, where available.

Onego Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Onego Bio's valuation, stock price, and market status.

Is Onego Bio a public or private company?

Onego Bio is a private company.

What is the current stock price of Onego Bio?

Onego Bio is a private company, so its shares have no public market price. Caplight tracks Onego Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Onego Bio worth (valuation)?

Onego Bio's valuation is estimated at $84.8M based on funding round data.

Can I buy Onego Bio stock?

Onego Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Onego Bio's last funding round?

Onego Bio's most recent funding round was Series A Extension on July 17, 2024.

Who are the main investors in Onego Bio?

Key investors in Onego Bio include Agronomics Limited, European Commission (Horizon Europe), NordicNinja VC.

Will Onego Bio IPO soon?

No public IPO plans have been announced for Onego Bio.

How can I track Onego Bio secondary market activity?

Caplight tracks bids, offers, and trades in Onego Bio's shares on secondary markets.

Firmographic Details

HeadquartersHelsinki
Employee Range44
Year Founded2022
Last FundingJul 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?